TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $858,759 | -14.3% | 55,511 | -13.0% | 0.03% | -16.1% |
| Q2 2023 | $1,001,862 | +1.3% | 63,772 | +6.4% | 0.03% | -8.8% |
| Q1 2023 | $988,894 | +81.3% | 59,928 | +71.4% | 0.03% | +47.8% |
| Q4 2022 | $545,423 | -19.4% | 34,963 | -33.0% | 0.02% | -25.8% |
| Q3 2022 | $677,000 | +14.4% | 52,192 | +23.7% | 0.03% | +14.8% |
| Q2 2022 | $592,000 | +26.0% | 42,186 | +28.6% | 0.03% | +17.4% |
| Q1 2022 | $470,000 | +107.0% | 32,813 | +97.2% | 0.02% | +76.9% |
| Q4 2021 | $227,000 | -16.5% | 16,643 | +0.1% | 0.01% | -45.8% |
| Q3 2021 | $272,000 | +7.9% | 16,630 | +11.2% | 0.02% | -7.7% |
| Q2 2021 | $252,000 | -21.0% | 14,958 | -14.3% | 0.03% | -45.8% |
| Q1 2021 | $319,000 | -10.1% | 17,446 | -10.7% | 0.05% | -37.7% |
| Q4 2020 | $355,000 | -4.3% | 19,528 | -6.1% | 0.08% | -26.0% |
| Q3 2020 | $371,000 | +18.5% | 20,796 | +19.0% | 0.10% | -26.8% |
| Q2 2020 | $313,000 | – | 17,473 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |